A Phase 3 randomized, masked, controlled trial to evaluate efficacy and safety of belzupacap sarotalocan (AU-011) treatment compared to sham control in subjects with primary indeterminate lesions or small choroidal melanoma
Categories (click each to see list of all clinical trials associated with that category): Ophthalmology (ONC)
Current Status: Open
Phase: III (Cancer Control)
Principal Investigator: Rishi, Pukhraj
Eligibility: https://clinicaltrials.gov/study/NCT06007690?term=NCT06007690&rank=1
Summary